• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: UTAH MEDICAL PRODUCTS, INC UMBILI-CATH; UMBILICAL CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

UTAH MEDICAL PRODUCTS, INC UMBILI-CATH; UMBILICAL CATHETER Back to Search Results
Catalog Number 4273505
Device Problem Material Split, Cut or Torn (4008)
Patient Problem Foreign Body In Patient (2687)
Event Date 12/21/2021
Event Type  Injury  
Event Description
On (b)(6) 2021, the patient required a uvc placement.On 12-21-2021, an order was placed to discontinue the use of the uvc.During removal, the catheter was severed and a surgical procedure was required to remove the remaining indwelling catheter segment.The patient tolerated the procedure well and the uvc was completely removed.The user confirmed that the securements, sutures and secureportiv adhesive, were not removed prior to the removal attempt.
 
Manufacturer Narrative
Utmd is reporting this event because the hospital staff stated that a surgical procedure was required to remove the severed segment of catheter tube from the patient.The hospital staff confirmed that the catheter was sutured in place and then secureportiv adhesive was applied to the catheter and sutures.The hospital staff also confirmed that neither the adhesive nor sutures were loosened or removed prior to the catheter removal attempt.The instructions for use provided with utmd's catheter state to loosen securements before adjusting the position of the catheter.
 
Manufacturer Narrative
Utmd is reporting this event because the hospital staff stated that a surgical procedure was required to remove the severed segment of catheter tube from the patient.The hospital staff confirmed that the catheter was sutured in place and then secureportiv adhesive was applied to the catheter and sutures.The hospital staff also confirmed that neither the adhesive nor sutures were loosened or removed prior to the catheter removal attempt.The instructions for use provided with utmd's catheter state to loosen securements before adjusting the position of the catheter.
 
Event Description
On (b)(6) 2021, the patient required a uvc placement.On (b)(6) 2021, an order was placed to discontinue the use of the uvc.During removal, the catheter was severed and a surgical procedure was required to remove the remaining indwelling catheter segment.The patient tolerated the procedure well and the uvc was completely removed.The user confirmed that the securements, sutures and secureportiv adhesive, were not removed prior to the removal attempt.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UMBILI-CATH
Type of Device
UMBILICAL CATHETER
Manufacturer (Section D)
UTAH MEDICAL PRODUCTS, INC
7043 south 300 west
midvale UT 84047
Manufacturer (Section G)
UTAH MEDICAL PRODUCTS, INC
7043 south 300 west
midvale UT 84047
Manufacturer Contact
ryan usgaard
7043 south 300 west
midvale, UT 84047
8015661200
MDR Report Key13362322
MDR Text Key285462796
Report Number1718873-2022-00001
Device Sequence Number1
Product Code FOS
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K940953
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type User Facility
Reporter Occupation Administrator/Supervisor
Type of Report Initial
Report Date 01/26/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/26/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue Number4273505
Device Lot Number1212617
Was Device Available for Evaluation? No
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age28 WK
-
-